Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | TGM2 | P21980 | 10/20 | 0.34 |
| ▸ | F13A1 | P00488 | 8/20 | 0.34 |
| ▸ | TGM1 | P22735 | 8/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | TGM3 | Q08188 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL33466 | 0.77 | MEN1 (0.37) | MEN1KMT2AALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL3116054 | 0.74 | ALDH1A1 (0.43) | MEN1KMT2AALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL1420537 | 0.73 | ALDH1A1 (0.46) | MEN1KMT2AALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL379428 | 0.73 | ALDH1A1 (0.42) | MEN1KMT2AALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL1420931 | 0.71 | ALDH1A1 (0.41) | MEN1KMT2AALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL27640713 | 0.71 | ALDH1A1 (0.44) | MEN1KMT2AALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL12264424 | 0.69 | KMT2A (0.42) | MEN1KMT2AALDH1A1MAPK1 | |
| SCHEMBL4314501 | 0.69 | ALDH1A1 (0.43) | MEN1KMT2AALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL26478897 | 0.69 | ALDH1A1 (0.40) | MEN1KMT2AALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL7101115 | 0.69 | ALDH1A1 (0.46) | MEN1KMT2AALDH1A1CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10479848-B2 | Addition-fragmentation oligomers | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-11-19 | — | — | US | disclosed |
| US-10370322-B2 | Addition-fragmentation agents | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-08-06 | — | — | US | disclosed |
| US-20180044448-A1 | ADDITION-FRAGMENTATION OLIGOMERS | 3M INNOVATIVE PROPERTIES COMPANY | 2018-02-15 | — | — | US | disclosed |
| US-20180044448-A1 | ADDITION-FRAGMENTATION OLIGOMERS | 3M INNOVATIVE PROPERTIES COMPANY | 2018-02-15 | — | — | US | disclosed |
| US-20170210693-A1 | ADDITION-FRAGMENTATION AGENTS | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2017-07-27 | — | — | US | disclosed |
| US-20170210693-A1 | ADDITION-FRAGMENTATION AGENTS | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2017-07-27 | — | — | US | disclosed |
| US-9463146-B2 | Addition-fragmentation oligomers | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2016-10-11 | — | — | US | disclosed |
| US-9463146-B2 | Addition-fragmentation oligomers | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2016-10-11 | — | — | US | disclosed |
| US-9403966-B2 | Addition-fragmentation agents | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2016-08-02 | — | — | US | disclosed |
| US-20150328086-A1 | ADDITION-FRAGMENTATION OLIGOMERS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2015-11-19 | — | — | US | disclosed |
| US-20150328086-A1 | ADDITION-FRAGMENTATION OLIGOMERS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2015-11-19 | — | — | US | disclosed |
| US-20150203658-A1 | ADDITION-FRAGMENTATION AGENTS | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2015-07-23 | — | — | US | disclosed |
| US-20130053508-A1 | ACRYLIC PRESSURE-SENSITIVE ADHESIVES WITH ACYLAZIRIDINE CROSSLINKING AGENTS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-02-28 | — | — | US | disclosed |
| US-8349962-B2 | Acrylic pressure-sensitive adhesives with acylaziridine crosslinking agents | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-01-08 | — | — | US | disclosed |
| WO-2012112304-A1 | ADDITION-FRAGMENTATION AGENTS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2012-08-23 | — | — | WO | disclosed |
| US-20120208965-A1 | ADDITION-FRAGMENTATION AGENTS | 3M INNOVATIVE PROPERTIES COMPANY | 2012-08-16 | — | — | US | disclosed |
| US-20120208965-A1 | ADDITION-FRAGMENTATION AGENTS | 3M INNOVATIVE PROPERTIES COMPANY | 2012-08-16 | — | — | US | disclosed |
| US-20120028043-A1 | ACRYLIC PRESSURE-SENSITIVE ADHESIVES WITH ACYLAZIRIDINE CROSSLINKING AGENTS | 3M INNOVATIVE PROPERTIES COMPANY | 2012-02-02 | — | — | US | disclosed |
| US-8067504-B2 | Acrylic pressure-sensitive adhesives with acylaziridine crosslinking agents | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2011-11-29 | — | — | US | disclosed |
| US-20110054115-A1 | ACRYLIC PRESSURE-SENSITIVE ADHESIVES WITH ACYLAZIRIDINE CROSSLINKING AGENTS | 3M INNOVATIVE PROPERTIES COMPANY | 2011-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10479848-B2 | Addition-fragmentation oligomers | ECPAS, ITGA8, NBAS | MEN1 4634/4885KMT2A 2118/4885ALDH1A1 2212/4885 |
| US-10370322-B2 | Addition-fragmentation agents | NR4A1, PARP14, MTX1 | MEN1 183/4885KMT2A 2178/4885ALDH1A1 3630/4885 |
| US-20110054115-A1 | ACRYLIC PRESSURE-SENSITIVE ADHESIVES WITH ACYLAZIRIDINE CROSSLINKING AGENTS | AAAS, PTK2, MDN1 | MEN1 981/4885KMT2A 265/4885ALDH1A1 492/4885 |
| US-20180044448-A1 | ADDITION-FRAGMENTATION OLIGOMERS | ECPAS, ITGA8, NBAS | MEN1 4634/4885KMT2A 2118/4885ALDH1A1 2212/4885 |
| US-20150328086-A1 | ADDITION-FRAGMENTATION OLIGOMERS | FGB, ZYX, APBA1 | MEN1 1855/4885KMT2A 4097/4885ALDH1A1 1881/4885 |
| US-20120208965-A1 | ADDITION-FRAGMENTATION AGENTS | NR4A1, PARP14, MTX1 | MEN1 183/4885KMT2A 2178/4885ALDH1A1 3630/4885 |
| US-20170210693-A1 | ADDITION-FRAGMENTATION AGENTS | NR4A1, PARP14, MTX1 | MEN1 183/4885KMT2A 2178/4885ALDH1A1 3630/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.